Melanoma is one of the most common malignant tumors in the world. It is characterized by its aggressive nature and rapid metastasis, which often leads to high treatment costs and rapid death of the patient.
Over the past 10 years, the number of patients diagnosed with melanoma for the first time in Belarus has increased by 1.5 times. Worldwide, the number of people diagnosed with melanoma doubles on average every 6-8 years.
In the United States alone, more than $3 billion is spent annually on treating melanoma patients, and by 2030 this figure is expected to triple compared to 2011.
Oncologist of the 1st category of the HappyDerm medical center Lyudmila Artyushkevich named several factors that can increase the likelihood of developing melanoma:
The introduction of new treatments, including targeted chemotherapy, has increased the cost of treating patients with metastatic melanoma but has not yet improved overall treatment outcomes. It is therefore important to focus on prevention and timely referral to a doctor for diagnosis and treatment of melanoma.
Although melanoma tumors can exhibit aggressive behavior, early detection and adequate surgical treatment can provide a good prognosis. However, prevention of melanoma development is most important.
To achieve this goal, it is recommended to take a set of simple measures:
The fight against melanoma is based on two main principles: prevention and early diagnosis.
Prevention of melanoma includes protection from adverse factors, mainly from excessive ultraviolet radiation, and removal of potentially dangerous formations.
Early diagnosis of melanoma includes regular self- and mutual examinations of the skin, visits to a dermato-oncologist, photo-documentation and dermatoscopy of neoplasms, as well as excision of suspicious formations for histological examination.
Addressing these key challenges will help achieve real results in the fight against melanoma.